Cardiometabolic Health: Updates in Hypertension and Dyslipidemia
Organization
About This Course
Cardiometabolic Health: Updates in Hypertension and Dyslipidemia
Hypertension in Diabetes · 2026 Dyslipidemia Guideline
A recorded course by consultants in endocrinology and diabetes covering the evidence behind blood pressure targets and drug choices in patients with diabetes, and what is new in the 2026 dyslipidemia guideline, from cardiovascular risk assessment to lipid treatment goals and non-statin therapies.
What you will learn
Course content
Your speakers
Who should attend
Curriculum Overview
This course includes 4 modules, 2 lessons, and 2:11 hours of materials.
Reviews why hypertension and diabetes are a deadly duo, the landmark trials behind blood pressure targets, and how to choose antihypertensive therapy per ADA recommendations.
Walks through what is new in the 2026 dyslipidemia guideline: PREVENT risk equations, LDL-C and non-HDL-C goals, lipoprotein(a), coronary calcium scoring and non-statin therapies.
15 multiple-choice questions covering hypertension management in patients with diabetes and the 2026 dyslipidemia guideline. Choose the single best answer for each question.
This is our evaluation survey. kindly fill it out, thanks in advance.
Please rate the quality of the activity on a scale of 1 (poor) to 5 (Excellent)
Quiz Certificate
Certificates
Enroll in this course to start earning its certificates.
Course Specifications
Reply to Comment